These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30683141)

  • 1. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling.
    Chiche A; Di-Cicco A; Sesma-Sanz L; Bresson L; de la Grange P; Glukhova MA; Faraldo MM; Deugnier MA
    Breast Cancer Res; 2019 Jan; 21(1):13. PubMed ID: 30683141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
    Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine Met signaling triggers epithelial-mesenchymal transition in mammary luminal progenitors, affecting their fate.
    Di-Cicco A; Petit V; Chiche A; Bresson L; Romagnoli M; Orian-Rousseau V; Vivanco Md; Medina D; Faraldo MM; Glukhova MA; Deugnier MA
    Elife; 2015 Jul; 4():. PubMed ID: 26165517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.
    Chiche A; Moumen M; Petit V; Jonkers J; Medina D; Deugnier MA; Faraldo MM; Glukhova MA
    Stem Cells; 2013 Sep; 31(9):1857-67. PubMed ID: 23712598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
    Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
    Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.
    Shehata M; Teschendorff A; Sharp G; Novcic N; Russell IA; Avril S; Prater M; Eirew P; Caldas C; Watson CJ; Stingl J
    Breast Cancer Res; 2012 Oct; 14(5):R134. PubMed ID: 23088371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proto-oncogene Myc is essential for mammary stem cell function.
    Moumen M; Chiche A; Deugnier MA; Petit V; Gandarillas A; Glukhova MA; Faraldo MM
    Stem Cells; 2012 Jun; 30(6):1246-54. PubMed ID: 22438054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors.
    Chiche A; Moumen M; Romagnoli M; Petit V; Lasla H; Jézéquel P; de la Grange P; Jonkers J; Deugnier MA; Glukhova MA; Faraldo MM
    Oncogene; 2017 Apr; 36(17):2355-2365. PubMed ID: 27775073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
    Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
    Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer.
    Knight JF; Lesurf R; Zhao H; Pinnaduwage D; Davis RR; Saleh SM; Zuo D; Naujokas MA; Chughtai N; Herschkowitz JI; Prat A; Mulligan AM; Muller WJ; Cardiff RD; Gregg JP; Andrulis IL; Hallett MT; Park M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):E1301-10. PubMed ID: 23509284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling.
    Chakrabarti R; Wei Y; Romano RA; DeCoste C; Kang Y; Sinha S
    Stem Cells; 2012 Jul; 30(7):1496-508. PubMed ID: 22523003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours.
    Tao L; Xiang D; Xie Y; Bronson RT; Li Z
    Nat Commun; 2017 Feb; 8():14431. PubMed ID: 28194015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.
    Jiang Z; Deng T; Jones R; Li H; Herschkowitz JI; Liu JC; Weigman VJ; Tsao MS; Lane TF; Perou CM; Zacksenhaus E
    J Clin Invest; 2010 Sep; 120(9):3296-309. PubMed ID: 20679727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Bonetti P; Climent M; Panebianco F; Tordonato C; Santoro A; Marzi MJ; Pelicci PG; Ventura A; Nicassio F
    Oncogene; 2019 Jan; 38(3):360-374. PubMed ID: 30093634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway.
    Kaenel P; Antonijevic M; Richter S; Küchler S; Sutter N; Wotzkow C; Strange R; Andres AC
    Int J Oncol; 2012 Feb; 40(2):357-69. PubMed ID: 22020958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity.
    Tornillo G; Elia AR; Castellano I; Spadaro M; Bernabei P; Bisaro B; Camacho-Leal Mdel P; Pincini A; Provero P; Sapino A; Turco E; Defilippi P; Cabodi S
    Stem Cells; 2013 Jul; 31(7):1422-33. PubMed ID: 23592522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland.
    Ranjan M; Lee O; Cottone G; Mirzaei Mehrabad E; Spike BT; Zeng Z; Yadav S; Chatterton R; Kim JJ; Clare SE; Khan SA
    Breast Cancer Res; 2021 Aug; 23(1):78. PubMed ID: 34344445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.